Pharmacokinetics of essential amino acids in chronic dialysis-patients. 1978

J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel

Possible disorders of essential amino acid (EAA) metabolism in maintenance dialysis patients (D) were studied by measuring plasma amino acids before and sequentially after administering a mixture of 8 EAA po and iv. The EAA were in a ratio similar to that required for optimal utilization, and the total dose given was within physiological range. Ten D and six normals (N) received 150 mg/kg po as a 10.5 g/dl solution and 117 mg/kg iv as a 5.1 g/dl solution infused at a constant rate of mg/kg per min. Blood glucose and immunoreactive insulin were also measured. Both D and N were postabsorptive and at least 18 hr postdialysis. The fraction of the oral dose appearing in the systemic circulation was variable for each EAA in both N and D. Total body clearance was significantly lower in D (P less than 0.05) for theronine, phenylalanine, valine, leucine, and isoleucine, and this difference could not be explained by changes in renal excretion. The apparent volume of distribution did not differ between N and D for all EAA except for valine and phenylalanine. Blood glucose insulin varied only slightly in both N and D for all EAA except for valine and phenylalanine. Blood glucose and insulin varied only slightly in both N and D. These studies indicate that there are a variety of significant abnormalities in the metabolism of specific EAA in D. Decreased total body clearance of the branched-chain amino acids, since they are primarily metabolized total body clearance of the brnached-chain amino acids, since they are primarily metabolized by muscle, may result from a defect in muscle metabolism in D.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000601 Amino Acids, Essential Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs. Essential Amino Acid,Essential Amino Acids,Acid, Essential Amino,Acids, Essential Amino,Amino Acid, Essential

Related Publications

J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
January 1978, Clinical science and molecular medicine,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
December 1991, Nihon rinsho. Japanese journal of clinical medicine,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
January 1976, Voprosy pitaniia,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
January 1993, Clinical therapeutics,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
June 1975, Clinical nephrology,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
January 1972, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
January 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
September 2010, World journal of gastroenterology,
J Chami, and M M Reidenberg, and D Wellner, and D S David, and A L Rubin, and K H Stenzel
October 1982, Zhonghua nei ke za zhi,
Copied contents to your clipboard!